刊名:Journal of Huazhong University of Science and Technology [Medical Sciences]
出版年:2008
出版时间:October 2008
年:2008
卷:28
期:5
页码:564-567
全文大小:361KB
参考文献:1. Constantino F, Ronald W B, Jerzy W K / et al. Hepatic ischemia/reperfusion injury—a fresh look. Exp Mol Pathol, 2003,74:86 CrossRef 2. Nakajima A, Wada K, Miki H / et al. Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology, 2001, 120: 460-69 CrossRef 3. Lawlor D K, Brock R W, Harrls K A / et al. Cytokines contribute to early hepatic parenchymal injury and microvascular dysfuntion after bilateral hind limb ischemia. J Vasc Surg, 1999,30(4):533-41 CrossRef 4. Yoshidome H, Kato A, Edwards M J / et al. Interleukin-10 suppresses hepatic-ischemia reperfusion injury in mice: implications of a control role for nuclear factor kappaB. Hepatology, 1999,30(2):203-08 CrossRef 5. Le Moine O, Louis H, Demols A / et al. Cold liver ischemia/reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology, 2000,31(6):1266-274 CrossRef 6. Murphy G J, Holder J C. PPAR-g agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci, 2000,21,469-74 CrossRef 7. Pascual L G, Glass C K. Peroxisome proliferator-activat ed receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol, 2000, 20:4699-707 CrossRef 8. Jiang C, Ting A T, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature, 1998,391:82-6 CrossRef 9. Wada K, Nakajima A, Takahashi H / et al. Protective effect of endogenous PPARγ against acute gastric mucosal lesions associated with ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol, 2004,287:G452–G458 CrossRef 10. Cuzzocrea S, Pisano B, Dugo L / et al. Rosiglitazone and 5-deoxy-delta12, 14-preostaglandinJ2, ligand of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischemia/reperfusion injury of the gut. Br J Pharmacol, 2003,140:366-76 CrossRef 11. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol, 2003,21:335-76 CrossRef 12. Zhai Y, Shen X D, O’Connell R / et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent Pathway. J Immunol, 2004,173:7115-119 13. Appel S, Mirakaj V, Bringmann A / et al. PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways. Blood, 2005,106:3888-894 CrossRef
1. Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China 3. Department of General Surgery, Affiliated Hospital of Hubei Institute for Nationalities, Enshi, 445000, China 2. Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China